These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 952097

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Semeiological value of so-called prostatic tartrate-labile acid phosphatases. (Critical study of 500 medical records)].
    von Niederhäusern W, Tuchschmid D.
    Ann Urol (Paris); 1970 Sep; 4(3):205-11. PubMed ID: 5472678
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Determination of activity of acid phosphatase in serum in prostatic diseases].
    Ianishevskaia AD.
    Lab Delo; 1967 Sep; 5():277-80. PubMed ID: 4184710
    [No Abstract] [Full Text] [Related]

  • 26. Laboratory assessment of prostate status.
    Saito Y.
    Clin Lab Med; 1993 Mar; 13(1):279-86. PubMed ID: 7681740
    [Abstract] [Full Text] [Related]

  • 27. Acid phosphatase isozymes in cancer of the prostate.
    Reif AE, Schlesinger RM, Fish CA, Robinson CM.
    Cancer; 1973 Mar; 31(3):689-99. PubMed ID: 4120927
    [No Abstract] [Full Text] [Related]

  • 28. The acid phosphatase isoenzymes in normal and pathological sera and in tissue homogenates.
    Rozenszajn L, Epstein Y, Shoham D, Arber I.
    J Lab Clin Med; 1968 Nov; 72(5):786-93. PubMed ID: 5697388
    [No Abstract] [Full Text] [Related]

  • 29. Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.
    Zweig MH, Ihde DC.
    Cancer Res; 1985 Aug; 45(8):3945-50. PubMed ID: 3893691
    [Abstract] [Full Text] [Related]

  • 30. [The acid and alkaline phosphatase activity in the serum of patients with prostatic cancer. The effect of endocrine therapy].
    Thijs LG, Poelman JR, Noll WL.
    Ned Tijdschr Geneeskd; 1969 Jul 26; 113(30):1303-9. PubMed ID: 5802998
    [No Abstract] [Full Text] [Related]

  • 31. [Behavior of serum acid phosphatases following specific immunotherapy of metastasizing prostatic carcinoma].
    Rothauge CF, Kraushaar J, Gutschank J, Sedlacek HH.
    Med Welt; 1981 Jan 09; 32(2):50-3. PubMed ID: 7207127
    [No Abstract] [Full Text] [Related]

  • 32. Acid phosphatases in human plasma.
    Li CY, Chuda RA, Lam WK, Yam LT.
    J Lab Clin Med; 1973 Sep 09; 82(3):446-60. PubMed ID: 4125586
    [No Abstract] [Full Text] [Related]

  • 33. [Studies on prostatic phosphatase. II. Study on serum acid phosphatase].
    Nakano S.
    Hinyokika Kiyo; 1969 Aug 09; 15(8):565-75. PubMed ID: 4186705
    [No Abstract] [Full Text] [Related]

  • 34. Clinical aspects of prostatic carcinoma.
    Foo KT, Tan EC, Tung KH, Lee YS.
    Singapore Med J; 1982 Oct 09; 23(5):269-72. PubMed ID: 7157007
    [No Abstract] [Full Text] [Related]

  • 35. Further experience with the Franzen transrectal prostatic biopsy needle.
    Ward JP.
    Ann Chir Gynaecol Fenn; 1974 Oct 09; 63(1):48-52. PubMed ID: 4134053
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prostatic cancer: diagnosis and prognosis.
    Karr JP, Slack NH, Murphy GP.
    Compr Ther; 1980 Oct 09; 6(10):34-41. PubMed ID: 7449363
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.